216 related articles for article (PubMed ID: 34777363)
1. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
Ghimire S; Weber D; Hippe K; Meedt E; Hoepting M; Kattner AS; Hiergeist A; Gessner A; Matos C; Ghimire S; Wolff D; Edinger M; Hoffmann P; Poeck H; Herr W; Holler E
Front Immunol; 2021; 12():753287. PubMed ID: 34777363
[TBL] [Abstract][Full Text] [Related]
2. Microbial metabolite sensor GPR43 controls severity of experimental GVHD.
Fujiwara H; Docampo MD; Riwes M; Peltier D; Toubai T; Henig I; Wu SJ; Kim S; Taylor A; Brabbs S; Liu C; Zajac C; Oravecz-Wilson K; Sun Y; Núñez G; Levine JE; van den Brink MRM; Ferrara JLM; Reddy P
Nat Commun; 2018 Sep; 9(1):3674. PubMed ID: 30201970
[TBL] [Abstract][Full Text] [Related]
3. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.
Docampo MD; da Silva MB; Lazrak A; Nichols KB; Lieberman SR; Slingerland AE; Armijo GK; Shono Y; Nguyen C; Monette S; Dwomoh E; Lee N; Geary CD; Perobelli SM; Smith M; Markey KA; Vardhana SA; Kousa AI; Zamir E; Greenfield I; Sun JC; Cross JR; Peled JU; Jenq RR; Stein-Thoeringer CK; van den Brink MRM
Blood; 2022 Apr; 139(15):2392-2405. PubMed ID: 34653248
[TBL] [Abstract][Full Text] [Related]
4. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
5. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
6. Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation.
Ghimire S; Ederer KU; Meedt E; Weber D; Matos C; Hiergeist A; Zeman F; Wolff D; Edinger M; Poeck H; Herr W; Gessner A; Holler E; Bülow S
Front Immunol; 2022; 13():857400. PubMed ID: 35572572
[TBL] [Abstract][Full Text] [Related]
7. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
[TBL] [Abstract][Full Text] [Related]
8. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy.
Feng Y; Huang Y; Wang Y; Wang P; Song H; Wang F
PLoS One; 2019; 14(6):e0218384. PubMed ID: 31211803
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
Mathewson ND; Jenq R; Mathew AV; Koenigsknecht M; Hanash A; Toubai T; Oravecz-Wilson K; Wu SR; Sun Y; Rossi C; Fujiwara H; Byun J; Shono Y; Lindemans C; Calafiore M; Schmidt TM; Honda K; Young VB; Pennathur S; van den Brink M; Reddy P
Nat Immunol; 2016 May; 17(5):505-513. PubMed ID: 26998764
[TBL] [Abstract][Full Text] [Related]
11. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.
Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H
J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041
[TBL] [Abstract][Full Text] [Related]
12. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota.
Chen D; Jin D; Huang S; Wu J; Xu M; Liu T; Dong W; Liu X; Wang S; Zhong W; Liu Y; Jiang R; Piao M; Wang B; Cao H
Cancer Lett; 2020 Jan; 469():456-467. PubMed ID: 31734354
[TBL] [Abstract][Full Text] [Related]
13. Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics.
Weber D; Hiergeist A; Weber M; Dettmer K; Wolff D; Hahn J; Herr W; Gessner A; Holler E
Clin Infect Dis; 2019 Apr; 68(8):1303-1310. PubMed ID: 30124813
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.
Simms-Waldrip TR; Sunkersett G; Coughlin LA; Savani MR; Arana C; Kim J; Kim M; Zhan X; Greenberg DE; Xie Y; Davies SM; Koh AY
Biol Blood Marrow Transplant; 2017 May; 23(5):820-829. PubMed ID: 28192251
[TBL] [Abstract][Full Text] [Related]
15. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
Markey KA; Schluter J; Gomes ALC; Littmann ER; Pickard AJ; Taylor BP; Giardina PA; Weber D; Dai A; Docampo MD; Armijo GK; Slingerland AE; Slingerland JB; Nichols KB; Brereton DG; Clurman AG; Ramos RJ; Rao A; Bush A; Bohannon L; Covington M; Lew MV; Rizzieri DA; Chao N; Maloy M; Cho C; Politikos I; Giralt S; Taur Y; Pamer EG; Holler E; Perales MA; Ponce DM; Devlin SM; Xavier J; Sung AD; Peled JU; Cross JR; van den Brink MRM
Blood; 2020 Jul; 136(1):130-136. PubMed ID: 32430495
[TBL] [Abstract][Full Text] [Related]
16. [Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease].
Wang ZD; Feng SZ; Zhou SY; Wang M; Zhou Z; Zhai WJ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1215-20. PubMed ID: 17204197
[TBL] [Abstract][Full Text] [Related]
17. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
Fujiwara H
Front Immunol; 2021; 12():703298. PubMed ID: 34512627
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids.
Wu H; Singer J; Kwan TK; Loh YW; Wang C; Tan J; Li YJ; Lai SWC; Macia L; Alexander SI; Chadban SJ
J Am Soc Nephrol; 2020 Jul; 31(7):1445-1461. PubMed ID: 32482686
[TBL] [Abstract][Full Text] [Related]
20. FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation.
Arimoto K; Kadowaki N; Ishikawa T; Ichinohe T; Uchiyama T
Int J Hematol; 2007 Feb; 85(2):154-62. PubMed ID: 17321995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
